Merck "good" cholesterol drug meets trial goals
225913
VIENNA/NEW YORK  - Merck & Co's combination pill to raise "good" HDL cholesterol with less facial flushing -- a common side effect of HDL drugs -- met its main goals in a late-stage test, researchers said on Sunday.
765930
U.S. regulators said on Friday they  would review a study showing a Merck and Schering-Plough  cholesterol drug worked no better than a generic in preventing  the build-up of arterial plaque.
586730
Its past success bodes well for its plans for a new blood pressure drug.
465044
NEW YORK (Dow Jones/AP) -- A high-dose regimen of Merck &amp; Co.&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of zocor in preventing a recurrence of cardiac events in patients who&#39;d already had heart
566145
The companies will not change the main endpoint of a study of their cholesterol drugs Zetia and Vytorin.
174409
The company's lead drug will enter phase 1 trials, bringing potential good fortune to investors.
584007
Investors reward the drugmaker for positive study results.
5284
Cholesterol-lowering drugs can lower the death risk of stroke patients, claim researchers.
505962
Cephalon gets some good news about its drug PROVIGIL.
292912
A Congressional committee is investigating Merck and Schering-Plough for their handling of a critical clinical trial of Zetia, their blockbuster cholesterol-lowering drug.
331284
The amount of "good cholesterol" in the blood remains an important marker for heart disease regardless of how much "bad cholesterol" is lowered, researchers said on Wednesday.
524021
Merck & Co.  said on Friday it would delay seeking approval for a combination pill designed to lower "bad" cholesterol, increase "good" cholesterol and avoid a common side effect of one of the ingredients.
101261
Following results of recent clinical trials on popular cholesterol drugs, cardiologists are questioning whether a patientâs cholesterol should be all that matters.
282642
The drug is safe; hopefully that's all the FDA wanted to know.
352694
Merck & Co.  expects to seek U.S. approval in 2007 for drugs to treat HIV, cholesterol and insomnia, and aims to have another four products in late-stage trials by mid-year, the company said on Tuesday.
115250
A high-dose regimen of Merck&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of Zocor in preventing a recurrence of cardiac events
506148
It's running trials to see if the drug can be used in earlier stages of cancer.